Publication | Open Access
Linking MedDRA®-Coded Clinical Phenotypes to Biological Mechanisms by the Ontology of Adverse Events: A Pilot Study on Tyrosine Kinase Inhibitors
24
Citations
32
References
2016
Year
Adverse EventsDrug DiscoveryPharmacologyPathologyMeddra®-coded Clinical PhenotypesTyrosine Kinase InhibitorsOmicsPharmacotherapyPharmacogenomicsMedicineAdverse Drug ReactionPharmacoepidemiology
| Year | Citations | |
|---|---|---|
Page 1
Page 1